Abivardi Signer Golnar sold (to issuer) 14,388,879 shares of VVVV (indirect holdings)

Abivardi Signer Golnar (Co-CEO, Co-Founder & Co-Chair) sold (to issuer) 14,388,879 indirectly-held shares of vVARDIS Holding AG (VVVV) on 2026-11-13.

Original reporting
SEC EDGAR · Abivardi Signer Golnar
Published Nov 13, 2026, 9:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$VVVV
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The insider sale could signal confidence concerns, potentially exerting downward pressure on the stock.

02

Market read

First‑report insider sale; material share count but no price, likely limited immediate market impact.

03

What to watch

No price disclosed; market may not react strongly without valuation context.

Relevance 6/10Novelty 7/10Timing: same-day filing

Background

SEC Form 4 filing discloses a sale of 14.4 million shares by co‑CEO Golnar Abivardi Signer of vVARDIS Holding AG.

Market effects

None

None

None

Counterpoint

Insider sale may reflect personal liquidity needs, not necessarily negative outlook.

Key entities

  • vVARDIS Holding AG

    Issuer of the Form 4 filing.

  • Golnar Abivardi Signer

    Co‑CEO and insider selling shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VVVVHighAI 8/10

New York Stock Exchange: vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update

vVardis (NYSE: VVVV) raised $175 million in its IPO, pricing 9.72 million shares at $18 each. The dental health firm offers a peptide-based treatment for early cavities. VAST Data secured $10 billion in commitments for its AI operating system. Kraft Heinz (NYSE: KHC) discussed growth plans after a 0.9% share price increase. Both vVardis and Revvity (NYSE: RVTY) celebrated milestones on the NYSE.